Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Pharmacogenetics and Genomics|November 16, 2016
Genome-wide association study of paliperidone efficacyQingqin Li, Nathan E Wineinger, Dong-Jing Fu, et al.Clinical Pharmacokinetics|April 24, 2009
Effect of the cytochrome P450 2C19 inhibitor omeprazole on the pharmacokinetics and safety profile of bortezomib in patients with advanced solid tumours, non-Hodgkin's lymphoma or multiple myelomaDavid I Quinn, John Nemunaitis, Jyotsna Fuloria, et al.Annals of Hematology|June 10, 2010
Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicinGabriele Buda, Deborah Ricci, C Chris Huang, et al.Pharmacogenomics|March 29, 2008
Case-control study of the association between select HLA genes and anti-erythropoietin antibody-positive pure red-cell aplasiaBonnie Fijal, Deborah Ricci, Els Vercammen, et al.Pharmacogenetics and Genomics|February 26, 2015
Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophreniaDai Wang, Dong-Jing Fu, Xiaodong Wu, et al.BMC Genetics|April 1, 2009
Robust physical methods that enrich genomic regions identical by descent for linkage studies: confirmation of a locus for osteogenesis imperfectaPeter Brooks, Charles Marcaillou, Maud Vanpeene, et al.Bioethics|May 10, 2006
Returning genetic research results to individuals: points-to-considerGaile Renegar, Christopher J Webster, Steffen Stuerzebecher, et al.Genome Medicine|December 2, 2017
Copy number variation meta-analysis reveals a novel duplication at 9p24 associated with multiple neurodevelopmental disordersJoseph T Glessner, Jin Li, Dai Wang, et al.Journal of Molecular Medicine (Berlin, Germany)|February 5, 2004
Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patientsAimée D C Paulussen, Ronaldus A H J Gilissen, Martin Armstrong, et al.Journal of Clinical Pharmacology|June 6, 2008
PhRMA white paper on ADME pharmacogenomicsJ Andrew Williams, Tommy Andersson, Tommy B Andersson, et al.Pageof 3